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Highlights  44 
 Endometriosis has been shown to increase pain sensitivity in fertile-aged 45 
women.  46 
 The study shows decreasd pain threshold and maximal pain tolerance in women 47 
with endometriosis at age 46  48 
 Women with endometriosis report increased pain sites and bothersome and 49 
intense pain at age 46 50 
 Delay in diagnosis of endometriosis may lead to increased pain sensitization 51 
 Endometriosis should be diagnosed and treated early on to ensure minimal 52 
comorbidity  53 
 54 
Abstract 55 
Previous studies have shown increased pain sensitivity in fertile-aged women with 56 
endometriosis in response to mechanical stimuli. As yet, population-based studies on the 57 
association of endometriosis with pain sensation and pain symptoms in late fertile age are 58 
lacking. The main objective of this population-based cohort study was to investigate 59 
whether a history of endometriosis is associated with altered pain sensation and 60 
musculoskeletal pain symptoms at age 46. 61 
Our data is derived from the Northern Finland Birth Cohort 1966, which contains postal 62 
questionnaire data (72% response rate) as well as clinical data assessing pressure-pain 63 
threshold (PPT) and maximal pain tolerance (MaxPTo). The study population consisted of 64 
284 women with endometriosis and 3390 controls. 65 
Our results showed that at age 46 women with a history of endometriosis had a 5.3% 66 
lower PPT and 5.1% lower maxPTo compared with controls. The most significant 67 
contributors besides endometriosis were anxiety, depression and current smoking status. 68 
Women with endometriosis also reported an increased number of pain sites (0 pain sites, 69 
9.6 vs. 17.9%; 5–8 pain sites, 24.8 vs. 19.1%, endometriosis vs. controls respectively, 70 
p<0.001), and their pain was more troublesome and intense. The results were adjusted for 71 




BMI, smoking, depressive/anxiety symptoms, education and use of hormonal 72 
contraceptives. 73 
This unique data revealed an altered pain sensation and a greater likelihood of reporting 74 
musculoskeletal pain at age 46 among women with a history of endometriosis. The results 75 
imply that endometriosis has a long-term footprint on affected women, thus underlying the 76 
need for psychological support and medical treatment beyond fertile age. 77 
 78 
 79 
Perspective item 80 
This is a population-based cohort study showing decreased pain threshold and maximal 81 
pain tolerance in women with endometriosis up till late fertile age of 46 years. The pain 82 
was also found to be more bothersome and intense compared with controls.   83 





Endometriosis is an estrogen-dependent, chronic gynecological disorder associated with 85 
pelvic pain and infertility, with a prevalence of 6–10% in the general population 6, 7, 13. 86 
Affected women experience dysmenorrhea, deep dyspareunia, dyschezia and dysuria 13, 37 87 
associated with low quality of life 8. The disorder is under-diagnosed or there is a delay in 88 
diagnosis in many cases leading to chronic pelvic pain (CPP) 7, 28. Diagnosis is made by 89 
laparoscopy or laparotomy, where endometrial lesions are found in extra-uterine locations, 90 
mainly the peritoneum and ovaries 6, 7, 13. As endometriosis is not curable, its treatments 91 
and therapies are targeted at infertility and symptom relief 7, 11. Endometriosis is also 92 
associated with other co-morbid conditions such as fibromyalgia and chronic fatigue 93 
syndrome 11, 28. Moreover, it has a significant adverse impact on work productivity, social 94 
activity, family responsibilities, and daily life, resulting in a substantial economic burden on 95 
society 11, 30. 96 
 It is well accepted that endometriosis is associated with dysmenorrhea, but it 97 
is not known why some women undergo transition to a state of chronic pain, while others 98 
do not1. Depending on the study population, 30–70% of women with CPP have 99 
laparoscopic evidence of endometriosis 21, 34. The pain symptoms, however, are poorly 100 
correlated to the severity of endometriosis, and the pathophysiology of endometriosis- 101 
associated pain remains somewhat elusive 9, 14, 23, 25, 36, 37. Pain mechanisms in 102 
endometriosis are thought to be multifactorial; pain may be nociceptive, neuropathic or a 103 
combination of these, and emotional, cognitive and behavioral components are also 104 
present 3, 20, 23, 32. Previous studies have shown increased pain sensitivity among women 105 
with endometriosis, with or without CPP, in response to mechanical stimuli compared with 106 
control 2. Furthermore, pain-threshold studies have suggested hyperalgesia at extra-pelvic 107 




sites, most likely due to peripheral and/or central sensitization mechanisms in affected 108 
women 5, 12, 16, 23, 24.  109 
Endometriosis is anticipated to subside in menopause, as it is an estrogen-110 
dependent disorder. However, in cases of peripheral and central sensitization, pain 111 
symptoms and hyperalgesia may persist beyond fertile age. As yet, no population-based 112 
data exist on pain symptoms among women with a history of endometriosis at late 113 
reproductive age. Thus, the aim of this study was to determine in a population-based 114 
cohort study setting whether women with a self-reported history of endometriosis 115 
experience altered pressure-pain sensitivity and adverse pain symptoms at age 46.  116 
 117 
Materials and Methods 118 
Study Population 119 
The study population originated from the Northern Finland Birth Cohort 1966 (NFBC1966, 120 
http://www.oulu.fi/nfbc) which is a unique, large, prospective, longitudinal dataset 121 
comprising all expected births in 1966 in the Northern Finland area (live-born children 122 
n=12058, females n=5889). Originally the cohort was established to investigate the life-123 
courses of various health-related conditions. Enrollment in this database began at the 24th 124 
gestational week, and, after birth, data-collection points were established at ages 1, 14, 31 125 
and 46 years, this study utilizing the latest data-collection point, thus being a secondary, 126 
cross-sectional analysis of a prospective study cohort. 127 
 At 46 years of age, all participants who were alive and whose postal address 128 
in Finland was known received a questionnaire (5123 women). This was the first 129 
questionnaire in this longitudinal cohort study including questions on history of 130 
endometriosis and pain symptoms. The response rate was 72%. Furthermore, all women 131 
were also invited to undergo clinical examination including pressure-pain testing, and 2774 132 




(55%) participated. All participants gave informed consent. The study followed the 133 
principles of the Declaration of Helsinki and the Ethics Committee of the Northern 134 
Ostrobothnia Hospital District approved the research. A flow chart of the study is shown in 135 
Figure 1.  136 
Diagnosis of Endometriosis 137 
The final analysis concerned all women self-reporting endometriosis, and those stating “no 138 
endometriosis” were considered as controls. Self-reported diagnosis was derived from the 139 
postal questionnaire item: “Have you ever been diagnosed with endometriosis by a 140 
physician?” resulting in an endometriosis population of 284 women (8% among women 141 
who answered the endometriosis question). There were 3390 women (92%) reporting no 142 
endometriosis and were considered as controls (Figure 1A).  143 
Verification of diagnosis 144 
Self-reported diagnosis of endometriosis has only recently been described in the literature 145 
26; hence the validity of the diagnosis was verified for the present study through the patient 146 
records available at the original study site at Oulu University Hospital (Supplemental 147 
Figure). Thirty-seven women (13%) did not give permission to enter their patient records. 148 
Of the 284 women with endometriosis we found patient records for 92 (32.4%). According 149 
to the patient records available, 71/92 women (77.2 %) were diagnosed as having 150 
endometriosis, of which 90.1% were established in laparoscopy/laparotomy. Fifteen 151 
women did not have a diagnosis of endometriosis and six were classified as unclear 152 
cases. It is possible that the diagnosis was established later in another hospital after 153 
moving from the area (groups “no endometriosis” and “unclear cases”). We also estimated 154 
the specificity of diagnoses from the national hospital discharge register including 155 
diagnosis established during hospital polyclinic visits or during hospitalization. In the 156 
endometriosis group 52% of the women also had a diagnosis in the national hospital 157 




discharge register, compared with 1.5% among the women reporting not having 158 
endometriosis (Table 1). Thus, we concluded that a self-reported history of endometriosis 159 
is sufficiently a valid tool to identify endometriosis cases in this cohort.  160 
Pressure-Pain Threshold (PPT) and Maximal Pain Tolerance (MaxPTo)  161 
Pain measurements were carried out in 2470 controls and 234 women with endometriosis. 162 
A few of the four measurement-site readings were missing as a result of technical 163 
difficulties. Pressure-pain threshold and maxPTo readings were acquired using an 164 
algometer (Somedic AB, Hörby, Sweden) with a 10-mm contact head, which was applied 165 
perpendicularly to the skin. Briefly, the pressure was increased from 0 kPa at a constant 166 
rate of 50 kPa/s. Instructions to participants were, “A pressure will be applied at a gradual 167 
rate. Allow the pressure to increase until it reaches a point where it feels uncomfortable 168 
and then press the button down. As we continue increasing the pressure, release the 169 
button when you cannot tolerate the pressure any more”. The former pressure value was 170 
recorded as the PPT and the latter as MaxPTo. Pressure was terminated at the latest 171 
when the safety maximum of 1200 kPa was reached. The PPT and MaxPTo 172 
measurements were taken at four anatomical sites in the following order: 1) shoulder; the 173 
mid–point of the upper trapezius muscle (subject in a prone position), 2) the mid-point of 174 
the tibialis anterior muscle (supine position), 3) the dorsal aspect of the wrist joint line 175 
(supine position), and 4) the L5/S1 interspinous space (prone position). The test sites were 176 
identified and participants were positioned in a standardized manner. Each site was tested 177 
twice. Of the peripheral sites, primarily the right side was used. The exact anatomical point 178 
of pressure was shifted slightly between the tests in order to prevent sensitization of 179 
nociceptors at the contact site. The highest value of the two measurements was used in 180 
the analysis to avoid overestimating pain threshold or tolerance. In addition, mean PPT 181 




and MaxPTo values at the four measured locations were calculated and used in the 182 
analyses.  183 
Questionnaires on pain sites, pain intensity and pain troublesomeness 184 
The numbers of musculoskeletal pain sites were assessed as follows: 0, 1, 2, 3, 4 or 5–8 185 
sites. The pain sites were derived from the questionnaire, in which the prevalence of 186 
musculoskeletal pain during the previous 12-month period was investigated as follows: 187 
“Have you had any aches or pains in the following areas of your body?” 1) neck, 2) 188 
shoulders, 3) arms/elbows, 4) wrists/hands/fingers, 5) lower back, 6) hips, 7) knees, and 8) 189 
ankles/feet. The anatomical sites were illustrated in a drawing. If there had been pain, 190 
there was a following question on the frequency of pain: “How often have you had aches 191 
or pains during the last 12 months?” 1) not at all, 2) 1–7 days, 3) 8–30 days, 4) over 30 192 
days, or 5) daily. If the person had experienced pain during the past 12 months, pain 193 
intensity and pain symptoms at work, during leisure time and sleep, at all musculoskeletal 194 
sites, were assessed by using a Numerical Rating Scale (NRS) off 0 (no pain / no 195 
disability) to 10 (extremely severe or disabling pain). 196 
Confounders 197 
Infertility 198 
Infertility was inquired about at age 46: “Have you ever suffered from infertility (yes/no)?” 199 
Parity 200 
Parity was inquired about at age 46: “How many deliveries you have experienced?” We 201 
divided the women according to parity into three groups: no delivery, one delivery or more 202 
than one delivery.  203 
 204 
 205 




Contraceptive use 206 
Current or past hormonal contraception use was inquired about at age 46 “Have you ever 207 
used any hormonal contraception (yes/no)?” and “Are you currently using hormonal 208 
contraception (yes/no)?”   209 
BMI 210 
Height and weight were both self-reported and measured at 46 years. In the clinical 211 
examinations, participants’ weight (kg) was measured with a digital scale, which was 212 
calibrated regularly. Height (cm) was measured twice by using a standard calibrated 213 
stadiometer. BMI (kg/m2) was calculated by using measured height (average of two 214 
measurements) and weight. Self-reported values were used if measured data was not 215 
available. There was no statistically significant difference between the self-reported and 216 
clinically measured BMI values. 217 
Smoking 218 
Smoking history and present smoking status were inquired about by way of two questions 219 
at the age of 46 years: 1) “Have you ever smoked (yes/no)?” and 2) “Are you currently 220 
smoking (yes/no)?” According to the answers we identified current and life-long 221 
nonsmokers.  222 
Alcohol use 223 
The subjects were also asked if they used alcohol, and if so, what kinds, how often and 224 
how much? Daily alcohol consumption was calculated according to the answers and 225 
classified three ways: 1) never, 2) light 3) moderate or heavy use (women >20g/day).   226 
Education 227 
Education was classified into three groups by the number of years of education: 9 years, 228 
9–12 years and more than 12 years. 229 
 230 




Anxiety and Depressive symptoms 231 
Anxiety and depressive symptoms were assessed via the 25-item Hopkins Symptom 232 
Checklist (HSCL-25) at 46 years of age 22, 35. HSCL-25 part I includes 10 items concerning 233 
anxiety symptoms and part II, 15 items concerning depression. The scale varies between 234 
1 and 4: 1 = not troublesome to 4 = extremely troublesome. The commonly used cut-off 235 
point of 1.55 was used to pinpoint anxiety and depression symptoms 35.  236 
Statistical analyses 237 
A Tobit regression model 33 was used to evaluate independent associations between 238 
endometriosis and PPT/MaxPTo. The motivation behind this was the large amount of 239 
censoring seen at the maximum limit of 1200 kPa. The interpretation of regression 240 
coefficients depends on the probability of not being censored. The interpretation is a 241 
combination of 1) the change in outcome, given that it is not censored, weighted by the 242 
probability of not being censored; and 2) the change in the probability of not being 243 
censored, weighted by the expected outcome if uncensored. Models were adjusted for 244 
BMI, anxiety and depression symptoms, smoking and contraceptive use.  245 
Chi-squared tests were used to analyze the associations between the distribution and 246 
numbers of pain sites, and ANOVA was used to investigate the effect of pain intensity and 247 
troublesomeness at work, during leisure time and sleep. The analyses were performed 248 
with R software version 3.2.2, using the AER package for Tobit regression19. 249 
 250 
Results 251 
The prevalence of self-reported endometriosis was 8% and verification of the diagnosis 252 
was carried out by examining the hospital records (Supplemental Figure). Table 1 shows 253 
the characteristics of the study women and the controls. Of note is the fact that in the self-254 
reported endometriosis group there was a relatively high percentage of women also having 255 




a diagnosis of endometriosis according to the hospital discharge register. The women with 256 
self-reported endometriosis were more often nulliparous and suffering from infertility, 257 
compared with controls. Use of hormonal contraceptives at any time was more frequent in 258 
women with endometriosis. No statistically significant differences were observed between 259 
the groups in terms of BMI, smoking, alcohol use or education level (Table 1).  260 
The distribution of pain perception in women according to different 261 
conditions/confounders at age 46 is shown in Figure 2. Self-reported endometriosis was 262 
associated with statistically significant decreases in both pressure-pain threshold (p<0.05, 263 
Fig. 2A) and maximal pain tolerance (p<0.001, Fig. 2B) and the decreases in these 264 
variables remained after adjusting for different confounders. Other contributing factors 265 
were depression, anxiety and smoking. Interestingly, BMI and contraceptive use at any 266 
time seemed to increase the pain thresholds (Fig 2).  267 
In Tobit regression analysis, PPT measurement showed that the women with 268 
endometriosis had on average a 34.0 kPa lower (-5.3% [-1.1,-9.5]) pain threshold 269 
compared with controls (p<0.05). As for the measurement site, PPT measured at the wrist 270 
was significantly lower in women reporting endometriosis (-37.5 kPa, p<0.05, Table 2), 271 
whereas the results concerning other measurement sites (shoulder, lower back and leg) 272 
did not differ between the study groups. After adjusting for confounders, PPT remained 273 
35.4 kPa lower in the endometriosis group (p<0.01). There were no statistically significant 274 
effects of BMI, anxiety, smoking or current or previous contraceptive use on pain threshold 275 
measured at the wrist. 276 
 Maximal pain tolerance was on average -48.2 kPa lower (-5.1% [-2.2, -8.1]) 277 
among women with endometriosis (p<0.001, Table 2) the change being significant at all 278 
measurement sites, even after adjusting for BMI, anxiety and depressive symptoms, 279 
smoking and contraceptive use (mean -51.2 kPa, p<0.001), wrist (-58.2kPa), shoulder (-280 




53.4 kPa), lower back (-58.0 kPa) and leg (-46.8 kPa).The most significant contributors 281 
besides endometriosis that lowered maximum pain tolerance were anxiety, depression and 282 
current smoking status (-29.7kPa, -28.5kPa, -34.2kPa, respectively) (p<0.05, Figure 2). 283 
The women were also screened for number of musculoskeletal pain sites (0, 284 
1, 2, 3, 4, 5–8 sites), pain troublesomeness and pain intensity (Fig. 3). Among women with 285 
endometriosis there were significantly fewer reporting no pain sites (9.6% vs. 17.9%, 286 
p<0.001, Fig. 3). Overall, the women with endometriosis also reported more pain sites 287 
compared with controls (1 site 17.4% vs. 16.2%, 2 sites 17.0% vs 18.5%, 3 sites 15.5% vs. 288 
16.2%, 4 sites 15.6% vs. 12.2% and 5–8 sites 24,8% vs 19,1%, p<0.001, Fig. 3). 289 
 As for pain troublesomeness, endometriosis was associated with slightly 290 
more troublesome pain at work and during leisure time and sleep (p=0.01, p=0.02, p=0.04 291 
respectively, Fig. 4A). After adjusting pain troublesomeness for smoking, BMI, depression, 292 
anxiety and contraceptive use it was still significant during work (p=0.04) whereas the 293 
significance was abolished for pain troublesomeness during leisure time and sleep 294 
(p=0.05, p=0.06, Fig. 4A). Adjusted overall pain intensity was also greater among women 295 
with endometriosis vs. controls (p=0.03, Fig. 4B).  296 
 297 
Discussion 298 
This is the first population-based study to show an altered musculoskeletal pain response 299 
and increased self-reported pain sensitivity, troublesomeness and intensity among women 300 
at late reproductive age with a history of endometriosis. The results indicate that 301 
endometriosis may have long-term consequences related to pain perception even at late 302 
reproductive years.  303 
 Our data show a lower pressure-pain threshold and lower maximal pain 304 
tolerance among 46-year-old women with a history of endometriosis compared with 305 




controls in a population-based study setting. The data adds to the body of evidence in the 306 
literature showing altered pain sensitivity in endometriosis. However, previous studies 307 
have been hospital-related populations1, 2, 4, 12. In the present study, regression analysis 308 
suggested that endometriosis is associated independently with lower pain threshold and 309 
tolerance, whereas the strongest factors further decreasing the pain threshold and the 310 
maximal pain response were anxiety, depression and current smoking status. Given all 311 
this, it is worth noting that depression has been previously shown to be associated with 312 
altered pain perception 15 and interestingly, musculoskeletal pain responses are 313 
particularly increased among women with co-expressing endometriosis and anxiety or 314 
depression symptoms 31. Interestingly, both past and current contraceptive use appeared 315 
to be associated with unchanged pain tolerance, supporting the clinical use of hormonal 316 
contraceptives also in women with pelvic pain. The role of estrogens in pain perception is, 317 
however, complex. Interestingly, low estrogen concentrations in late menstrual cycle or 318 
during menopause or increased estrogen-testosterone ratio in male to female transsexuals 319 
have been shown to associate with increased pain symptoms 38. Whether menopause 320 
solves the endometriosis-related altered pain responses or make them worse remains to 321 
be evaluated in future studies as estrogen measurements or menopausal status were not 322 
available for the present study.   323 
As for individual pain-measurement sites, the pain threshold measured at the 324 
wrist in women with endometriosis was significantly lower compared with that in the 325 
controls. A similar trend was also shown at other pain-measurement sites. To our 326 
knowledge, ours is the first population based study to show decreased MaxPTo at several 327 
measurement sites among women of late reproductive age with a history of endometriosis, 328 
compared with controls and the results are in line with several previous studies also 329 
showing altered pain responses in women with endometriosis. In a previous study in which 330 




pressure-pain sensitivity was assessed in the thumbnail, the results showed significantly 331 
lower pain threshold among women with symptomatic endometriosis 2. Visceral 332 
hypersensitivity testing also revealed lower pain thresholds among women with 333 
endometriosis in a rectal balloon dilation test 18 and lower pain thresholds and larger pain 334 
areas were reported in women with symptomatic endometriosis after an intramuscular 335 
saline injection into the hand 4. In a more recent study concerning pressure-pain 336 
thresholds at 20 different body sites, with use of the visual analog scale, it was reported 337 
that there was a lower pain threshold in the greater trochanter and abdomen in fertile-aged 338 
women with endometriosis compared with controls 24. A population-based study carried 339 
out by Slater et al., with similar musculoskeletal pain response testing as in the present 340 
study, showed decreased pain thresholds in women experiencing severe menstrual pain29. 341 
Given that about 70% of women with dysmenorrhea (CPP) present with endometriosis in 342 
laparoscopy, the data by Slater et al. are in line with the present results underlying altered 343 
pain perception in affected women. The mechanisms behind the lowered threshold are 344 
most likely multifactorial, involving peripheral and central mechanisms 23. Whether the 345 
women with CPP are the ones who also have altered pain perception during late 346 
reproductive years remains to be investigated as the present data did not record 347 
dysmenorrhea or pelvic pain. 348 
 Women with endometriosis reported more pain sites, and graded pain to be 349 
more bothersome and intense compared with controls. This might be due to central and/or 350 
peripheral sensitization which has been shown to result from prolonged noxious pain 351 
stimulation sustaining central pain stimulation in these cases 17, 31. Indeed, women with 352 
endometriosis have reported increased regional hyperalgesia and allodynia 31. Moreover, 353 
the fact that pelvic pain correlates poorly with findings/severity of endometriosis further 354 
emphasizes the fact that central and/or peripheral sensitization is most likely involved in 355 




the pain-regulatory system among affected women 3, 31. All in all, delayed diagnosis and 356 
prolonged pain sensations may bring about altered pain sensitization among women with 357 
endometriosis. 358 
  There are several strengths but also some limitations in the present work. 359 
This is the first population-based study carried out to investigate pain perception/sensitivity 360 
related to a history of endometriosis in women of late reproductive age. Women with 361 
endometriosis were identified from a unique, large population-based data set of 362 
homogeneous ethnicity and age and with the possibility to adjust for several confounding 363 
factors. The data included objective pain measurements as well as subjective 364 
questionnaire data. Moreover, the data collection did not specifically target endometriosis 365 
patients or patients only treated in hospitals. Hence, the questionnaires and clinical 366 
measurements were carried out in the whole cohort, with minimal self-aware bias. The 367 
study also has limitations, which include self-reported endometriosis diagnosis and lack of 368 
data on clinical symptoms of endometriosis; thus it is possible that the control group also 369 
included women with endometriosis, albeit with milder pain symptoms/sensitivity. 370 
However, the control group in the present data set was fairly large and such cases would 371 
have been diluted among the controls. Moreover, studies on endometriosis commonly 372 
concern only laparoscopically verified cases, and thus women with endometriosis with 373 
fewer pain symptoms are most likely underrepresented in these studies. The self-reported 374 
diagnoses of endometriosis may also be considered as a limitation, although, the 375 
diagnosis was validated from the patient records available and from the national hospital 376 
discharge register. In a recent study by Saha et al, similar results were presented when 377 
self-reported endometriosis diagnoses were verified from patient records 26. This was 378 
further supported by a recent study validating self-reported endometriosis diagnosis in a 379 
Swedish national twin registry27. The authors concluded that self-reported diagnosis 380 




seems to be moderately accurate, and when additional information is also available the 381 
accuracy is even better. It must be noted, however, that even though laparoscopy is the 382 
gold standard in endometriosis diagnosis, in some milder cases the operation is not 383 
justified and thus the diagnosis remains clinical. Although our measurements showed 384 
statistically significant 5% decreases in pain threshold and maximal pain tolerance in 385 
women with endometriosis, the clinical significance remains uncertain, although these 386 
women also self-reported more pain symptoms. Furthermore, the associations between 387 
endometriosis-related pain symptoms and other comorbid pain syndromes, menopause or 388 
estradiol levels were not investigated due to lack of available data, thus these aspects 389 
remain to be evaluated in future studies.   390 
To conclude, this is the first population-based study showing a decreased pain 391 
threshold and a decreased maximal pain response among women of late fertile age with a 392 
history of endometriosis. The fact that the women also reported a higher number of pain 393 
sites, with a greater prevalence of troublesome and intense pain at age 46 underlines the 394 
fact that endometriosis may have a long-term footprint as regards pain perception in these 395 
women. Given all this, women with endometriosis symptoms should be screened and 396 
diagnosed as early as possible by a multidisciplinary team in order to ensure minimal 397 
comorbidity, adequate pain relief and psychological support. Further studies are warranted 398 
to address the diagnostic difficulties and different endometriosis phenotypes and also to 399 











We thank Tuula Ylitalo for assisting with data acquisition. We thank Dr. Nick Bolton for 407 
correcting English.  408 





1. As-Sanie S, Harris RE, Napadow V, Kim J, Neshewat G, Kairys A, Williams D, Clauw 410 
DJ Schmidt-Wilcke T: Changes in regional gray matter volume in women with chronic 411 
pelvic pain: a voxel-based morphometry study. Pain 153 5:1006-1014, 2012 412 
2. As-Sanie S, Harris RE, Harte SE, Tu FF, Neshewat G Clauw DJ: Increased pressure 413 
pain sensitivity in women with chronic pelvic pain. Obstet Gynecol 122 5:1047-1055, 2013 414 
3. As-Sanie S, Kim J, Schmidt-Wilcke T, Sundgren PC, Clauw DJ, Napadow V Harris RE: 415 
Functional Connectivity is Associated With Altered Brain Chemistry in Women With 416 
Endometriosis-Associated Chronic Pelvic Pain. J Pain 17 1:1-13, 2016 417 
4. Bajaj P, Bajaj P, Madsen H Arendt-Nielsen L: Endometriosis is associated with central 418 
sensitization: a psychophysical controlled study. J Pain 4 7:372-380, 2003 419 
5. Brawn J, Morotti M, Zondervan KT, Becker CM Vincent K: Central changes associated 420 
with chronic pelvic pain and endometriosis. Hum Reprod Update 20 5:737-747, 2014 421 
6. Burney RO Giudice LC: Pathogenesis and pathophysiology of endometriosis. Fertil 422 
Steril 98 3:511-519, 2012 423 
7. Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D'Hooghe T, De Bie B, 424 
Heikinheimo O, Horne AW, Kiesel L, Nap A, Prentice A, Saridogan E, Soriano D, Nelen W 425 
European Society of Human Reproduction and Embryology: ESHRE guideline: 426 
management of women with endometriosis. Hum Reprod 29 3:400-412, 2014 427 
8. Facchin F, Barbara G, Saita E, Mosconi P, Roberto A, Fedele L Vercellini P: Impact of 428 
endometriosis on quality of life and mental health: pelvic pain makes the difference. J 429 
Psychosom Obstet Gynaecol 36 4:135-141, 2015 430 
9. Fauconnier A Chapron C: Endometriosis and pelvic pain: epidemiological evidence of 431 
the relationship and implications. Hum Reprod Update 11 6:595-606, 2005 432 
10. Fraser IS: Mysteries of endometriosis pain: Chien-Tien Hsu Memorial Lecture 2009. J 433 
Obstet Gynaecol Res 36 1:1-10, 2010 434 
11. Gao X, Outley J, Botteman M, Spalding J, Simon JA Pashos CL: Economic burden of 435 
endometriosis. Fertil Steril 86 6:1561-1572, 2006 436 
12. Giamberardino MA, Tana C Costantini R: Pain thresholds in women with chronic pelvic 437 
pain. Curr Opin Obstet Gynecol 26 4:253-259, 2014 438 
13. Giudice LC Kao LC: Endometriosis. Lancet 364 9447:1789-1799, 2004 439 
14. Gruppo Italiano per lo Studio dell'Endometriosi: Relationship between stage, site and 440 
morphological characteristics of pelvic endometriosis and pain. Hum Reprod 16 12:2668-441 
2671, 2001 442 




15. Hermesdorf M, Berger K, Baune BT, Wellmann J, Ruscheweyh R Wersching H: Pain 443 
Sensitivity in Patients With Major Depression: Differential Effect of Pain Sensitivity 444 
Measures, Somatic Cofactors, and Disease Characteristics. J Pain , 2016 445 
16. Howard FM: Endometriosis and mechanisms of pelvic pain. J Minim Invasive Gynecol 446 
16 5:540-550, 2009 447 
17. Imamura M, Imamura ST, Kaziyama HH, Targino RA, Hsing WT, de Souza LP, Cutait 448 
MM, Fregni F Camanho GL: Impact of nervous system hyperalgesia on pain, disability, 449 
and quality of life in patients with knee osteoarthritis: a controlled analysis. Arthritis Rheum 450 
59 10:1424-1431, 2008 451 
18. Issa B, Onon TS, Agrawal A, Shekhar C, Morris J, Hamdy S Whorwell PJ: Visceral 452 
hypersensitivity in endometriosis: a new target for treatment? Gut 61 3:367-372, 2012 453 
19. Kleiber C, Zeileis A SpringerLink: Applied Econometrics with R. , 2008 454 
20. Kucyi A, Salomons TV Davis KD: Cognitive behavioral training reverses the effect of 455 
pain exposure on brain-network activity. Pain , 2016 456 
21. Laufer MR, Goitein L, Bush M, Cramer DW Emans SJ: Prevalence of endometriosis in 457 
adolescent girls with chronic pelvic pain not responding to conventional therapy. J Pediatr 458 
Adolesc Gynecol 10 4:199-202, 1997 459 
22. Mattisson C, Bogren M Horstmann V: Correspondence between clinical diagnoses of 460 
depressive and anxiety disorders and diagnostic screening via the Hopkins Symptom 461 
Check List-25 in the Lundby Study. Nord J Psychiatry 67 3:204-213, 2013 462 
23. Morotti M, Vincent K Becker CM: Mechanisms of pain in endometriosis. Eur J Obstet 463 
Gynecol Reprod Biol , 2016 464 
24. Nunes FR, Ferreira JM Bahamondes L: Pain threshold and sleep quality in women 465 
with endometriosis. Eur J Pain 19 1:15-20, 2015 466 
25. Porpora MG, Koninckx PR, Piazze J, Natili M, Colagrande S Cosmi EV: Correlation 467 
between endometriosis and pelvic pain. J Am Assoc Gynecol Laparosc 6 4:429-434, 1999 468 
26. Saha R, Kuja-Halkola R, Tornvall P Marions L: Reproductive and Lifestyle Factors 469 
Associated with Endometriosis in a Large Cross-Sectional Population Sample. J Womens 470 
Health (Larchmt) , 2016 471 
27. Saha R, Marions L Tornvall P: Validity of self-reported endometriosis and 472 
endometriosis-related questions in a Swedish female twin cohort. Fertil Steril 107 1:174-473 
178.e2, 2017 474 
28. Sinaii N, Cleary SD, Ballweg ML, Nieman LK Stratton P: High rates of autoimmune and 475 
endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among 476 
women with endometriosis: a survey analysis. Hum Reprod 17 10:2715-2724, 2002 477 




29. Slater H, Paananen M, Smith AJ, O'Sullivan P, Briggs AM, Hickey M, Mountain J, 478 
Karppinen J Beales D: Heightened cold pain and pressure pain sensitivity in young female 479 
adults with moderate-to-severe menstrual pain. Pain 156 12:2468-2478, 2015 480 
30. Soliman AM, Yang H, Du EX, Kelley C Winkel C: The direct and indirect costs 481 
associated with endometriosis: a systematic literature review. Hum Reprod 31 4:712-722, 482 
2016 483 
31. Stratton P, Khachikyan I, Sinaii N, Ortiz R Shah J: Association of chronic pelvic pain 484 
and endometriosis with signs of sensitization and myofascial pain. Obstet Gynecol 125 485 
3:719-728, 2015 486 
32. Tarjanne S, Ng CH, Manconi F, Arola J, Mentula M, Maneck B, Fraser IS Heikinheimo 487 
O: Use of hormonal therapy is associated with reduced nerve fiber density in deep 488 
infiltrating, rectovaginal endometriosis. Acta Obstet Gynecol Scand 94 7:693-700, 2015 489 
33. Tobin J: Estimation of Relationships for Limited Dependent Variables. Econometrica 490 
26 1:24-36, 1958 491 
34. Triolo O, Lagana AS Sturlese E: Chronic pelvic pain in endometriosis: an overview. J 492 
Clin Med Res 5 3:153-163, 2013 493 
35. Veijola J, Jokelainen J, Laksy K, Kantojarvi L, Kokkonen P, Jarvelin MR Joukamaa M: 494 
The Hopkins Symptom Checklist-25 in screening DSM-III-R axis-I disorders. Nord J 495 
Psychiatry 57 2:119-123, 2003 496 
36. Vercellini P, Trespidi L, De Giorgi O, Cortesi I, Parazzini F Crosignani PG: 497 
Endometriosis and pelvic pain: relation to disease stage and localization. Fertil Steril 65 498 
2:299-304, 1996 499 
37. Vercellini P, Vigano P, Somigliana E Fedele L: Endometriosis: pathogenesis and 500 
treatment. Nat Rev Endocrinol 10 5:261-275, 2014 501 
38. Vincent K Tracey I: Hormones and their Interaction with the Pain Experience. Rev Pain 502 
2 2:20-24, 2008 503 
   504 




Figure 1.  Flowchart showing the study population (nendometriosis = 284, ncontrols = 3390) 505 
derived from Northern Finland Birth Cohort 1966. 506 
 507 
Figure 2. Pain perception in women according to different conditions/confounders 508 
at  509 
age 46. The horizontal reference line reflects the whole study population. Self-reported 510 
endometriosis appeared to result in decreases in both pressure pain threshold (PPT) 511 
(p<0.05, A), and maximum pressure pain tolerance (MaxPTo) (p<0.001, B) compared with 512 
the effect of BMI and contraceptive use at any time. 513 
 514 
Figure 3. The numbers of reported pain sites in women with endometriosis (black) 515 
and in controls (gray) at age 46. Percentages of women experiencing 0, 1, 2, 3, 4 or 5–8 516 
pain sites per year. Fewer women with endometriosis (black bars) reported having no pain 517 
sites compared with controls (gray bars) (p<0.001). The numbers of pain sites were 518 
increased in women with endometriosis compared with controls (p<0.001). 519 
 520 
Figure 4. Pain troublesomeness (A) and intensity (B) in women with endometriosis 521 
and in controls at age 46. A) The mean pain troublesomeness score was increased in 522 
women with endometriosis (black bars) compared with controls (gray bars) at work. A 523 
similar trend was seen during leisure and sleep. B) The women with endometriosis 524 
reported having more intense pain compared with controls. Mean numerical rating (MNR) 525 
is the mean of pain scoring from 0 to 5. 526 
 527 




Suppelemental Figure. Validation of 284 self-reported endometriosis diagnosis was 528 









Table 1. Patient characteristics in women with self-reported endometriosis and controls at 










Endometriosis diagnosis in the national 
hospital discharge registry 52.0 1.5  
    
Suffering from infertility  33.8 14.1 <0.001 
    
No delivery 13.9 9.8  
<0.001 
 
One delivery 24.2 16.2 
More than one delivery 61.9 73.9 
    
Use of hormonal contraceptives    
  Ever 93.3 89.2 0.033 
  Current 20.2 27.1 0.028 
    
BMI (kg/m2)    
<18.5 0.8 0.9 
0.676 18.5 - 24.999 48.5 45.4 25 - 29.999 32.8 32.8 
≥30  17.8 20.9 
    
Smoking    
Ever 51.4 52.3 
0.804 Current 33.6 32.6 
    
Alcohol use    
Never 6.0 6.2 
0.603 Light (less than monthly) 11.7 11.7 
Moderate/heavy (at least once in a month) 76.3 77.7 
    
Education    
Basic 1.8 2.3  
0.072 
 
Secondary 50.7 57.1 
Tertiary 47.5 40.6 









Table 2. Tobit regression analysis of pressure pain threshold (PPT) and maximal pain tolerance (MaxPTo) in women with endometriosis compared with controls 1 
 Average 
Location of pressure pain measurement 
 
Wrist Shoulder Lower back Leg 
 
kPa (95% CI) kPa (95% CI) kPa (95% CI) kPa (95% CI) kPa (95% CI) 
Observations (total) n=2609 n=2730 n=2747 n=2635 n=2738 
      #Constant PPT (crude) 642.6 (634.2, 650.9) 648.8 (639.6, 657.9) 585.8 (575.8, 595.8) 710.2 (699.1, 721.3) 641.1 (630.7, 651.5) 
Endometriosis PPT (crude) -34.0* (-60.8, -7.3) -37.5* (-67.3, -7.7) -27.8 (-58.9, 3.2) -26.9 (-63.0, 9.1) -29.9 (-63.5, 3.7) 
^Difference [%] 
-5.3% (-1.1,-9.5) -5.8% (-1.2, -10.4) -4.8% (0.5, -10.1) -3.8% (1.3, -8.9) -4.7% (0.6, -9.9) 
      Constant PPT (adjusted)** 645.7 (620.9, 670.6) 648.6 (620.8, 676.4) 602.1 (572.3, 631.9) 690.8 (657.4, 724.1) 649.1 (617.3, 680.8) 
Endometriosis PPT (adjusted)** -35.4* (-62.2, -8.6) -36.4* (-66.3, -6.6) -25.7 (-56.5, 5.0) -33.8 (-69.5, 2.0) -31.3 (-65.0, 2.3) 
^Difference [%] -5.5% (-1.3, -9.6) -5.6% (-1.0, -10.2) -4.3% (0.8, -9.4) -4.9% (0.3, -10.1) -4.8% (0.4, -10.0) 
      Constant MaxPTo (crude) 939.9 (932.0, 947.9) 932.2 (922.5, 941.8) 957.8 (946.2, 969.4) 1031.3 (1018.9, 1043.8) 941.4 (989.1, 1069.1) 
Endometriosis MaxPTo (crude) -48.2* (-76.1, -20.4) -58.1* (-90.6, -25.6) -55.4* (-93.1, -17.7) -50.6* (-91.0, -10.2) -43.7* (-81.0, -6.3) 
^Difference [%] -5.1% (-2.2, -8.1) -6.2% (-2.7, -9.7) -5.8% (-1.8, -9.7) -4.9% (-1.0, -8.8) -4.6% (-0.7, -8.6) 
      Constant MaxPTo (adjusted)** 952.7 (928.2, 977.3) 930.8 (901.7, 960.0) 997.5 (962.2, 1032.7) 1029.1 (989.1, 1069.1) 953.2 (917.4, 989.0) 
Endometriosis MaxPTo (adjusted)** -50.1* (-78.0, -22.2) -58.2* (-90.8, -25.6) -53.4* (-90.7, -16.2) -58.0* (-97.8, -18.1) -46.8* (-84.2, -9.5) 
^Difference [%] -5.3% (-2.3, -8.2) -6.3% (-2.8, -9.8) -5.4% (-1.6, -9.1) -5.6% (-1.8, -9.5) -4.9% (-1.0, -8.8) 
*p<0.05           2 
**Adjusted for BMI, anxiety and depressive symptoms, smoking and use of hormonal contraceptives   3 
#Constant, a built estimate reference value for subjects with BMI at the mean level of the population, no significant anxiety or depressive symptoms, never smoker and no 4 
 use of hormonal contraceptives  5 
^Difference compared with controls 6 
 7 
 8 
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